FDA Approved: OTULFI — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for OTULFI (ustekinumab-aauz) from Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Plaque Psoriasis
• Psoriatic Arthritis
• Ulcerative Colitis

Drugs mentioned

• OTULFI (USTEKINUMAB-AAUZ)

Snippet

SUPPL AP for OTULFI (USTEKINUMAB-AAUZ)